immunePCS LLC provides preclinical consulting services that help our clients navigate the costly and time consuming drug discovery/development pipeline to develop innovative and exceptional products. We enable Biotechnology and Pharmaceutical companies to design and pinpoint the precise models most appropriate for their drug development programs in immuno-oncology. By supporting companies in the immunology and oncology domain immunePCS helps you through all the preclinical phases of drug discovery and preclinical development for both small molecules and large biologics.
The drug discovery and development process is a lengthy and expensive that involves multiple phases including:

• Hit to lead discovery, optimization and target validation
• Proof of concept using in vitro and in vivo testing
• Toxicology and safety assessment to IND filing

At each phase, from the conception of the idea through preclinical development and translation to the clinical setting, immunePCS offers the necessary expertise to plan and design studies by leveraging over 30 years of experience. With our help, your company receives the knowledge and experience in both basic science and translational medicine in immunology and oncology. Let immunePCS guide you through each of the phases to success. 

Click the image to access our brochure.

---